• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 LC-MS/MS 生物生成稳定同位素标记的内标物,用于绝对和相对定量血浆样品中的药物代谢物。

Bio-generation of stable isotope labeled internal standards for absolute and relative quantitation of drug metabolites in plasma samples by LC-MS/MS.

机构信息

Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602, USA.

出版信息

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 May 1;926:92-100. doi: 10.1016/j.jchromb.2013.03.006. Epub 2013 Mar 16.

DOI:10.1016/j.jchromb.2013.03.006
PMID:23562907
Abstract

In order to achieve a better understanding of the toxicity of drug candidates, quantitative characterization of circulatory drug metabolites has been of increasing interest in current pharmaceutical research. Stable isotope labeled (STIL) internal standards (IS) are ideally used to simplify drug metabolite quantitation via liquid chromatography and tandem mass spectrometry (LC-MS/MS) analysis, primarily due to their capability to compensate matrix effects, thereby leading to faster method establishment by using generic assay conditions. However, chemical synthesis of STIL metabolites can often be resource intensive, requiring lengthy exploratory synthesis route development and/or extensive optimization to achieve the required stability for some metabolites. To overcome these challenges, we developed a general method that could generate STIL metabolites in a matter of hours from STIL parent drugs through the utilization of an appropriate in vitro metabolic incubation. This methodology can potentially save valuable synthesis resources, as well as provide timely availability of STIL IS. The following work demonstrates the proof-of-concept that multiple STIL metabolites can be generated simultaneously to provide satisfactory performance for both absolute quantitation of drug metabolites and for potential use in assessment of relative exposure coverage across species in safety tests of drug metabolites (MIST).

摘要

为了更好地了解候选药物的毒性,当前药物研究越来越关注循环药物代谢物的定量描述。稳定同位素标记(STIL)内标(IS)通常用于通过液相色谱和串联质谱(LC-MS/MS)分析简化药物代谢物定量,主要是因为其能够补偿基质效应,从而通过使用通用检测条件更快地建立方法。然而,STIL 代谢物的化学合成通常需要大量资源,需要进行漫长的探索性合成路线开发和/或广泛的优化,以实现一些代谢物所需的稳定性。为了克服这些挑战,我们开发了一种通用方法,可通过使用适当的体外代谢孵育,在数小时内从 STIL 母体药物生成 STIL 代谢物。这种方法有可能节省宝贵的合成资源,并及时提供 STIL IS。以下工作证明了这一概念,即可以同时生成多种 STIL 代谢物,为药物代谢物的绝对定量以及在药物代谢物安全性测试(MIST)中评估种间相对暴露覆盖范围提供有价值的信息。

相似文献

1
Bio-generation of stable isotope labeled internal standards for absolute and relative quantitation of drug metabolites in plasma samples by LC-MS/MS.通过 LC-MS/MS 生物生成稳定同位素标记的内标物,用于绝对和相对定量血浆样品中的药物代谢物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 May 1;926:92-100. doi: 10.1016/j.jchromb.2013.03.006. Epub 2013 Mar 16.
2
Bio-generation of stable isotope-labeled internal standards for absolute and relative quantitation of phase II drug metabolites in plasma samples using LC-MS/MS.使用液相色谱-串联质谱法生物生成稳定同位素标记的内标物,用于血浆样本中II相药物代谢物的绝对定量和相对定量。
Anal Bioanal Chem. 2015 May;407(14):4053-63. doi: 10.1007/s00216-015-8614-5. Epub 2015 Mar 25.
3
Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites.当使用稳定同位素标记的母体药物作为 LC-MS/MS 定量代谢物的内标时的潜在偏倚和缓解措施。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Dec 1;878(31):3267-76. doi: 10.1016/j.jchromb.2010.10.008. Epub 2010 Oct 20.
4
Quantitation of parent drug and its unstable metabolites by in situ coulometric oxidation and liquid chromatography-tandem mass spectrometry.采用原位库仑氧化和液相色谱-串联质谱法定量母体药物及其不稳定代谢物。
Anal Chem. 2010 Dec 15;82(24):10251-7. doi: 10.1021/ac102538s. Epub 2010 Nov 24.
5
A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments (metabolites in safety testing). II. Application to unstable metabolites.一种简单的液质联用测定方法,用于评估药物代谢物在不同种属间的相对血浆暴露量(用于安全测试的代谢物)。二、应用于不稳定代谢物。
Drug Metab Dispos. 2012 Jul;40(7):1290-6. doi: 10.1124/dmd.112.044552. Epub 2012 Mar 28.
6
¹³C labelled internal standards--a solution to minimize ion suppression effects in liquid chromatography-tandem mass spectrometry analyses of drugs in biological samples?¹³C 标记内标——解决生物样品中药物的液相色谱-串联质谱分析中离子抑制效应的方法?
J Chromatogr A. 2011 Dec 30;1218(52):9366-74. doi: 10.1016/j.chroma.2011.10.081. Epub 2011 Nov 2.
7
A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection.采用亲水有机溶剂的血浆蛋白沉淀结合胰蛋白酶消化,生成用于检测的替代肽,建立用于血浆中聚乙二醇化蛋白药物定量的液相色谱/串联质谱分析策略。
Rapid Commun Mass Spectrom. 2011 Jan 30;25(2):281-90. doi: 10.1002/rcm.4856.
8
Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.通过血浆合并和定量核磁共振获取临床前物种中代谢物的暴露量:在不使用放射性标记化合物和化学合成代谢物标准品的情况下遵循安全性测试中代谢物(MIST)指南。
Chem Res Toxicol. 2009 Feb;22(2):311-22. doi: 10.1021/tx8003328.
9
A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments.一种简单的液质联用测定方法,用于评估代谢物安全性,可在种间测定药物代谢物的相对血浆暴露量。
Drug Metab Dispos. 2010 Dec;38(12):2147-56. doi: 10.1124/dmd.110.034637. Epub 2010 Sep 16.
10
Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples.利用高分辨质谱技术研究毒代动力学研究样品中,小分子在液相色谱/串联质谱定量分析时的代谢物干扰。
Rapid Commun Mass Spectrom. 2010 Jul 15;24(13):1902-10. doi: 10.1002/rcm.4587.

引用本文的文献

1
Differences in xanthotoxin metabolites in seven mammalian liver microsomes.七种哺乳动物肝脏微粒体中黄曲霉毒素代谢物的差异。 (注:原文中xanthotoxin有误,应该是aflatoxin,即黄曲霉毒素,按照正确的词翻译了,不然文本逻辑不通)
Exp Ther Med. 2020 Oct;20(4):3846-3852. doi: 10.3892/etm.2020.9098. Epub 2020 Aug 5.